BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 21425106)

  • 1. [Myoclonias secondary to gabapentin in a patient with chronic renal failure].
    Prieto-Pérez L; Montastruc J; García-Ruiz PJ
    Rev Neurol; 2011 Apr; 52(8):512. PubMed ID: 21425106
    [No Abstract]   [Full Text] [Related]  

  • 2. Gabapentin-induced severe myoclonus in a patient with impaired renal function.
    Holtkamp M; Halle A; Meierkord H; Masuhr F
    J Neurol; 2006 Mar; 253(3):382-3. PubMed ID: 16133721
    [No Abstract]   [Full Text] [Related]  

  • 3. Gabapentin-induced coma in a patient with renal failure.
    Dogukan A; Aygen B; Berilgen MS; Dag S; Bektas S; Gunal AI
    Hemodial Int; 2006 Apr; 10(2):168-9. PubMed ID: 16623669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gabapentin-induced myoclonus in an elderly with end-stage renal failure.
    Shea YF; Mok MM; Chang RS
    J Formos Med Assoc; 2014 Sep; 113(9):660-1. PubMed ID: 25103080
    [No Abstract]   [Full Text] [Related]  

  • 5. Pregabalin- and gabapentin-associated myoclonus in a patient with chronic renal failure.
    Healy DG; Ingle GT; Brown P
    Mov Disord; 2009 Oct; 24(13):2028-9. PubMed ID: 19642217
    [No Abstract]   [Full Text] [Related]  

  • 6. A probable case of gabapentin-related reversible hearing loss in a patient with acute renal failure.
    Pierce DA; Holt SR; Reeves-Daniel A
    Clin Ther; 2008 Sep; 30(9):1681-4. PubMed ID: 18840374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral fixed drug eruption caused by gabapentin.
    Gupta S; Gupta S; Mittal A; David S
    J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1207-8. PubMed ID: 19250328
    [No Abstract]   [Full Text] [Related]  

  • 8. Gabapentin toxicity in renal failure: the importance of dose adjustment.
    Miller A; Price G
    Pain Med; 2009 Jan; 10(1):190-2. PubMed ID: 18721173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gabapentin-Induced myoclonus: case report.
    Ege F; Koçak Y; Titiz AP; Oztürk SM; Oztürk S; Ozbakir S
    Mov Disord; 2008 Oct; 23(13):1947-8. PubMed ID: 18702113
    [No Abstract]   [Full Text] [Related]  

  • 10. Dyskinesia induced by gabapentin in idiopathic Parkinson's disease.
    Raju PM; Walker RW; Lee MA
    Mov Disord; 2007 Jan; 22(2):288-9. PubMed ID: 17089397
    [No Abstract]   [Full Text] [Related]  

  • 11. Asterixis related to gabapentin intake: a case report and review.
    Wahba M; Waln O
    Postgrad Med; 2013 Sep; 125(5):139-41. PubMed ID: 24113672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gabapentin-induced myoclonus in end-stage renal disease.
    Zhang C; Glenn DG; Bell WL; O'Donovan CA
    Epilepsia; 2005 Jan; 46(1):156-8. PubMed ID: 15660783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentin-induced neurologic toxicities.
    Bookwalter T; Gitlin M
    Pharmacotherapy; 2005 Dec; 25(12):1817-9. PubMed ID: 16305301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabapentin withdrawal: case report in an older adult and review of the literature.
    Mah L; Hart M
    J Am Geriatr Soc; 2013 Sep; 61(9):1635-7. PubMed ID: 24028370
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary and rectal incontinence during gabapentin therapy.
    Iyer R; Egloff L; Fraas J; Harris JD
    J Support Oncol; 2008 Apr; 6(4):152. PubMed ID: 18491681
    [No Abstract]   [Full Text] [Related]  

  • 16. Negative myoclonus induced by gabapentin and pregabalin: A case series and systematic literature review.
    Kim JB; Jung JM; Park MH; Lee EJ; Kwon DY
    J Neurol Sci; 2017 Nov; 382():36-39. PubMed ID: 29111014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gabapentin toxicity in patients with chronic kidney disease: a preventable cause of morbidity.
    Zand L; McKian KP; Qian Q
    Am J Med; 2010 Apr; 123(4):367-73. PubMed ID: 20362757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 71-year-old man with chronic kidney failure and sudden change of mental status.
    Mansfield AS; Qian Q
    Mayo Clin Proc; 2009 Nov; 84(11):e5-8. PubMed ID: 19880683
    [No Abstract]   [Full Text] [Related]  

  • 19. Six cases of (severe) hypoglycaemia associated with gabapentin use in both diabetic and non-diabetic patients.
    Scholl JH; van Eekeren R; van Puijenbroek EP
    Br J Clin Pharmacol; 2015 May; 79(5):870-1. PubMed ID: 25387462
    [No Abstract]   [Full Text] [Related]  

  • 20. Alopecia associated with gabapentin in the treatment of neuropathic pain.
    Eker HE; Cok OY; Aribogan A
    J Pain Symptom Manage; 2009 Mar; 37(3):e5-6. PubMed ID: 19268809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.